Heart transplant patients may soon avoid Long-Term kidney damage
NCT ID NCT06478017
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 27 times
Summary
This study tests whether a drug called belatacept can safely replace the standard anti-rejection drug tacrolimus in heart transplant patients. The goal is to prevent organ rejection while reducing the kidney damage often caused by tacrolimus. About 66 heart transplant recipients will be randomly assigned to receive either standard care or belatacept with a gradual reduction of tacrolimus over 9 months. Researchers will monitor for rejection, kidney function, and survival for 18 months after transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART TRANSPLANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cedars Sinai Heart Institute/ Cedars Sinai Medical (Site # 71146)
RECRUITINGLos Angeles, California, 90048, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
NYU Langone Health (Site # 71177)
RECRUITINGNew York, New York, 10016, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
St. Luke's Hospital of Kansas City
RECRUITINGKansas City, Missouri, 64111, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tampa General Hospital (Site # 71150)
RECRUITINGTampa, Florida, 33606, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Utah Medical Center (Site # 71126)
RECRUITINGSalt Lake City, Utah, 84132, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.